1. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells
   Halina Was et al, 2019, Clinical Epigenetics CrossRef
2. Effect of valproic acid on overall survival in patients with high-grade gliomas undergoing temozolomide
   Yu-Jen Kuo et al, 2020, Medicine CrossRef
3. The function of histone methylation and acetylation regulators in GBM pathophysiology
   Colin McCornack et al, 2023, Frontiers in Oncology CrossRef
4. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma—Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation
   Andra V. Krauze et al, 2023, Biomolecules CrossRef
5. Valproic Acid: A Promising Therapeutic Agent in Glioma Treatment
   Wei Han et al, 2021, Frontiers in Oncology CrossRef
6. Alteration of intracellular metabolome in osteosarcoma stem cells revealed by liquid chromatography-tandem mass spectrometry
   Zhihui Zhong et al, 2019, Talanta CrossRef
7. The Epigenetics of Glioma Stem Cells: A Brief Overview
   Luis M. Valor et al, 2020, Frontiers in Oncology CrossRef
8. The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells
   Philip Dao Trong et al, 2023, Cells CrossRef
9. Defining a Correlative Transcriptional Signature Associated with Bulk Histone H3 Acetylation Levels in Adult Glioblastomas
   Irati Hervás-Corpión et al, 2023, Cells CrossRef
10. Diazepam diminishes temozolomide efficacy in the treatment of U87 glioblastoma cell line
    Jovana Drljača et al, 2022, CNS Neuroscience & Therapeutics CrossRef
11. Under explored epigenetic modulators: role in glioma chemotherapy
    Yan-Hong Chen et al, 2018, European Journal of Pharmacology CrossRef
12. Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation
    Gabriele Riva et al, 2018, Genes CrossRef
13. Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?
    Chiara Cilibrasi et al, 2016, PPAR Research CrossRef
14. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells
    R. Gajendra Reddy et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
15. Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review
    Muhamad N.A. Kamarudin et al, 2019, Oncotarget CrossRef
16. Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
    Andrew M. Hersh et al, 2022, Cancers CrossRef
17. Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines
    Anna-Maria Barciszewska et al, 2022, Frontiers in Oncology CrossRef
18. Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [18F]TFAHA
    Maxwell T. Laws et al, 2019, Scientific Reports CrossRef
19. Translational gap in ongoing clinical trials for glioma
    Alecia Florence Guishard et al, 2018, Journal of Clinical Neuroscience CrossRef